Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use

Cancer Research

Volumn 66, Issue 13, 2006, Pages 6877-6883

  Chia, Victoria M ^a,b   Newcomb, Polly A ^a,b,c   Bigler, Jeannette ^a   Morimoto, Libby M ^a   Thibodeau, Stephen N ^d   Potter, John D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG USE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC STABILITY; GENETIC VARIABILITY; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COCARCINOGENESIS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SMOKING;

EID: 33746308114     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1535     Document Type: Article

References (57)

1. Giovannucci E, Martinez ME. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J Natl Cancer Inst 1996;88:1717-30.
2. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-31.
3. Giovannucci E, Rimm E, Stampfer M, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86:183-91.
4. Giovannucci E, Colditz G, Stampfer M, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994;86:192-9.
5. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of U.S. veterans and a review. Int J Cancer 1994;59:728-38.
6. Hsing AW, McLaughlin JK, Chow W, et al. Risk factors for colorectal cancer in a prospective study among U.S. white men. Int J Cancer 1998;77:549-53.
7. Knekt P, Hakama M, Jarvinen R, Pukkala E, Heliovaara M. Smoking and risk of colorectal cancer. Br J Cancer 1998;78:136-9.
8. Newcomb PA, Storer BE, Marcus PM. Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 1995;55:4906-9.
9. Chao A, Thun M, Jacobs E, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000;92:1888-96.
10. Slattery ML, Potter JD, Friedman GD, Ma KN, Edwards S. Tobacco use and colon cancer. Int J Cancer 1997;70:259-64.
11. Sturmer T, Glynn RJ, Lee I, Christen WG, Hennekens CH. Lifetime cigarette smoking and colorectal cancer in the Physicians' Health Study I. J Natl Cancer Inst 2000;92:1178-81.
12. Terry P, Ekbom A, Lichenstein P, Feychting M, Wolk A. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001;91:585-7.
13. Terry PD, Miller AB, Rohan TE. Prospective cohort study of cigarette smoking and colorectal cancer risk in women. Int J Cancer 2002;99:480-3.
14. Tiemersma EW, Kampman E, de Mesquita HBB, et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 2002;13:383-93.
15. Yamada K, Araki S, Tamura M, et al. Case-control study of colorectal carcinoma in situ and cancer in relation to cigarette smoking and alcohol use (Japan). Cancer Causes Control 1997;8:780-5.
16. Rubin H. Synergistic mechanisms in carcinogenesis by polycyciic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 2001;22:1903-30.
17. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
18. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
19. Slattery ML, Anderson K, Curtin K, et al. Dietary intake and microsatellite instability in colon tumors. Int J Cancer 2001;93:601-7.
20. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001;61:126-30.
21. Wu AH, Shibata D, Yu MC, Lai MY, Ross RK. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcinogenesis 2001;22:1681-4.
22. Chao A, Gilliland F, Willman C, et al. Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol Biomarkers Prev 2000;9:539-44.
23. Morimoto LM, Newcomb PA, Ulrich CM, et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 2002;11:1012-8.
24. Giovannucci E, Rimm E, Stampfer M, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
25. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
26. Thun MJ, Namboodiri MM, Heath CJ, Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
27. Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999;159:161-6.
28. Rosenberg L, Palmer JR, Zauber AG, et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8.
29. Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 1996;5:955-60.
30. Collet JP, Sharpe C, Belzile E, et al. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 1999;81:62-8.
31. Coogan PF, Rosenberg L, Louik C, et al. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control 2000;11:249-55.
32. Garcia Rodriguez LA, Huerta-Alvarez C. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 2000;11:376-81.
33. Greenberg ER, Baron JA, Freeman DH, Jr., Mandel JS, Haue R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 1993;85:912-6.
34. Breuer-Katehinski B, Nemes K, Rump B, et al. Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas. The Colorectal Adenoma Study Group. Digestion 2000;61:129-34.
35. Martinez ME, McPherson RS, Levin B, Annegers JF. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995;4:703-7.
36. Bigler J, Whitton J, Lampe JW, et al. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 2001;61:3566-9.
37. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
38. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90.
39. Giovannucci E. The prevention of colorectal cancer by aspirin use. Biomed Pharmacother 1999;53:303-8.
40. Newcomb P, Haile R, Anton-Culver H, et al. The Colorectal Cancer Family Registry: 1998-2002. Cancer Epidemiol Biomarkers Prev 2002;11:1222-3S.
41. Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: WHO; 1990.
42. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
43. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-8.
44. Breslow NE, Day NE. Statistical methods in cancer research. Volume I. The analysis of case-control studies. IARC Sci Publ Vol. 32. Lyon: IARC; 1980.
45. Yang P. Cunningham JM, Hailing KC, et al. Higher risk of mismatch repair-deficient colorectal cancer in α(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab 2000;71:639-45.
46. Newcomb PA, Carbone PP. The health consequences of smoking: cancer. In: M. Fiore, editor. The Medical Clinics of North America-cigarette smoking. Philadelphia: W. B. Saunders Company; 1992. p. 305-31.
47. IARC.Tobacco smoking, IARC Monogr Eval Carcinog Risk Chem Hum, vol. 38. Lyon: IARC; 1986.
48. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
49. Mu D, Tursun M, Duckett DR, et al. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol Cell Biol 1997;17:760-9.
50. Wu X, Zhao H, Suk R, Christian! DC. Genetic susceptibility to tobacco-related cancer. Oncogene 2004;23:6500-23.
51. Thun MJ, Henley SJ, Patrono C. Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002;94:252-66.
52. Patrignani P. Nonsteroidal anti-inflammatory drugs, COX-2, and colorectal cancer. Toxicol Lett 2000;112-3:493-8.
53. Morimoto L, Newcomb PA, Mandelson M, et al. Smoking and NSAID use in relation to hyperplastic and adenomatous polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2003;12:1282s.
54. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
55. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000;37:295-301.
56. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001;93:1307-13.
57. Jacobson JS, Neugut AI, Murray T, et al. Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 1994;5:215-20.